alexa Biopsy findings in renal allograft dysfunction in a live related renal transplant program
Surgery

Surgery

Journal of Transplantation Technologies & Research

Author(s): Kazi JI, Mubarak M

Abstract Share this page

Renal transplantation is the treatment modality of choice for patients with end-stage renal disease (ESRD) throughout the world [1]. The short-term renal transplant outcomes has improved markedly during the last few decades due to improved surgical techniques, better medical care, prevention and treatment of infections, but above all, due to advancements in the field of immunosuppressive treatment [1]. Despite the above accomplishments, renal allograft dysfunction is still common after transplantation and may be caused by acute rejection, chronic rejection, calcineurin inhibitor (CNI) toxicity, infections and other rare causes such as recurrence of original renal disease. Each of the above causes of renal allograft dysfunction requires different therapeutic approach and hence accurate diagnosis is essential for the optimal management of the patients [2]. Clinical diagnosis is unreliable as shown by several studies reporting inability to accurately predict the cause of graft dysfunction in 40 to 70% of cases based on the clinical criteria alone [3-7]. Renal allograft biopsy is the gold standard to accurately establish the cause of renal allograft dysfunction [3,8,9]. It is generally felt that the causes of graft dysfunction vary in live related vs. cadaveric renal transplant settings as well as in different immunosuppressive protocols [10-21]. There are also center to center, and inter-institutional variations in the quality and the incidence of rejection [22-26]. There are very few studies exclusively on the causes of graft dysfunction in a live related renal transplant program [10-15]. The estimated incidence of ESRD in Pakistan is 100 per million population (pmp), with approximately 18,000 new cases each year. More than 90% of the ESRD population in this country is disfranchised from renal replacement therapy (RRT), 10% receive dialysis and 4–5% receive transplants at a rate of <5 pmp [16]. We undertook this preliminary study to evaluate the causes of renal graft dysfunction as detected on renal allograft biopsies in a fairly large cohort of live related renal transplant patients and to compare our findings with those in the literature.

  • To read the full article Visit
  • Open Access
This article was published in J Transplant Tech Res and referenced in Journal of Transplantation Technologies & Research

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords